Yousif Capital Management LLC Increases Stock Position in Teleflex Incorporated (NYSE:TFX)

Yousif Capital Management LLC boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 149.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,031 shares of the medical technology company’s stock after buying an additional 10,813 shares during the quarter. Yousif Capital Management LLC’s holdings in Teleflex were worth $2,492,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of TFX. T. Rowe Price Investment Management Inc. lifted its stake in shares of Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock worth $1,098,693,000 after purchasing an additional 261,279 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Teleflex by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock worth $202,161,000 after buying an additional 8,307 shares during the last quarter. Cooke & Bieler LP lifted its position in Teleflex by 22.1% during the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after acquiring an additional 195,150 shares during the last quarter. Invesco Ltd. boosted its stake in Teleflex by 48.1% in the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company’s stock valued at $190,188,000 after acquiring an additional 347,003 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its holdings in Teleflex by 38.1% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company’s stock worth $105,102,000 after purchasing an additional 162,950 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE:TFX opened at $119.93 on Friday. The firm’s fifty day moving average is $126.73 and its two-hundred day moving average is $152.40. The firm has a market cap of $5.30 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 1.73 and a beta of 1.10. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $118.70 and a one year high of $249.91.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same period last year, the company earned $3.21 earnings per share. Research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 20th. This represents a $1.36 annualized dividend and a yield of 1.13%. Teleflex’s dividend payout ratio is presently 42.90%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Mizuho set a $155.00 price objective on Teleflex in a research report on Wednesday, April 16th. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Royal Bank of Canada lowered their target price on shares of Teleflex from $150.00 to $145.00 and set a “sector perform” rating for the company in a research note on Friday, May 2nd. Finally, Truist Financial dropped their target price on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a research report on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Hold” and an average target price of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.